Vimarsana
Biggest News Aggregation in the World

Oint Inflammation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oint Inflammation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oint Inflammation Today - Breaking & Trending Today

Most RA Patients Meet EMA's JAK Inhibitor Warning Criteria - Vimarsana News

Most RA Patients Meet EMA's JAK Inhibitor Warning Criteria

Recent regulatory warnings could mean that four in five patients with RA may not be prescribed JAK inhibitors unless there is no other alternative.

Lower CVD Risk With Stable DMARD Therapy in Seropositive RA - Vimarsana News

Lower CVD Risk With Stable DMARD Therapy in Seropositive RA

Patients with seropositive RA on stable DMARD therapy showed a CVD risk comparable with that of the general population, unlike those whose treatment regimen was not stable.

Reasons for Heightened Thrombotic Risk in RA Remain Unclear - Vimarsana News

Reasons for Heightened Thrombotic Risk in RA Remain Unclear

Irrespective of age, duration of disease, and other factors, people with rheumatoid arthritis have a consistently higher risk for venous thromboembolism than the general population.

Rheumatology Data Reflect Poor Adoption of ICD-10 - Vimarsana News

Rheumatology Data Reflect Poor Adoption of ICD-10

Inflammatory arthritis codes increased from 14 to 425 from ICD-9 to ICD-10, yet only nine codes were commonly used in practice from 2015 to 2021.

Two Biosimilars Approved in Europe for Autoimmune Disorders - Vimarsana News

Two Biosimilars Approved in Europe for Autoimmune Disorders

The drugs are intended to treat several types of arthritis, psoriasis, COVID-19, and Crohn's disease.